Diagnosis of breast cancer in countries with limited resources

Breast Journal

Volumn 9, Issue SUPPL. 2, 2003, Pages

  Vargas, Hernan I ^a   Anderson, Benjamin O ^b   Chopra, Rakesh ^c   Lehman, Constance D ^b   Ibarra, Julio A ^d   Masood, Shahla ^e   Vass, Laszlo ^f  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INDRAPRASTHA APOLLO HOSPITAL   (India)

^d LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f Hospital of Pest County   (Hungary)

Author keywords

Core needle biopsy; Developing countries; Diagnosis; Fine needle aspiration biopsy; Imaging; Surgical biopsy; Triple test

Indexed keywords

ANAMNESIS; ASPIRATION BIOPSY; BIOPSY TECHNIQUE; BREAST CANCER; BREAST DISEASE; BREAST EXAMINATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; CORE NEEDLE BIOPSY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HUMAN; INTERNATIONAL COOPERATION; MAMMOGRAPHY; MICROSCOPIC ANATOMY; MINIMALLY INVASIVE SURGERY; NEEDLE BIOPSY; PATHOLOGICAL ANATOMY; PATIENT COUNSELING; PREDICTION; PROGNOSIS; RELIABILITY; RESOURCE MANAGEMENT; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

BIOPSY, NEEDLE; BREAST NEOPLASMS; DEVELOPING COUNTRIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HEALTH RESOURCES; HUMANS; MAMMOGRAPHY; MASTECTOMY; MEDICAL HISTORY TAKING; NEOPLASM STAGING; PALPATION; PATHOLOGY; QUALITY ASSURANCE, HEALTH CARE; WORLD HEALTH ORGANIZATION;

EID: 0038362746     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.9.s2.5.x     Document Type: Conference Paper

References (39)

1. World Health Organization. Executive summary. In: National Cancer Control Programmes: Policies and Managerial Guidelines. Geneva, Switzerland: WHO, 2002:i-xxiv.
2. Anderson BO, Braun S, Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J 2003;9(suppl 2):S42-S50.
3. Anderson BO, Braun S, Smith RA, Taplin S, Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J 2003;9(suppl 2):S51-S89.
4. Weiss NS. Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J 2003;9(suppl 2):S86-S89.
5. Albert US, Schulz KD. Clinical breast examination: what can be recommended for its use to detect breast cancer in countries with limited resources? Breast J 2003;9(suppl 2):S90-S93.
6. Margolesse RG, Fisher B, Hortobagyi GN, Bloomer WD. Neoplasms of the breast. In: Bast RC Jr, Kufe DW, Pollock RE, et al., eds. Holland Frei Cancer Medicine, 5th ed. Hamilton, Ontario, Canada: BC Decker, 2000:1735-822.
7. Butler J, Vargas H, Worthen N, Wilson S. Accuracy of combined clinical-mammographic-cytologic diagnosis of dominant breast masses: a prospective study. Arch Surg 1990;125:893-96.
8. Vetto J, Pommier R, Schmidt W, et al. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings. Am J Surg 1995;169:519-22.
9. Vargas HI, Masood S. Implementation of a minimally invasive breast biopsy program in countries with limited resources. Breast J 2003;9(suppl 2):S78-S81.
10. Winchester DP, Cox JD. Standards for breast-conservation treatment. CA Cancer J Clin 1992;42:134-62.
11. Egan RL. Bilateral breast carcinoma: role of mammography. Cancer 1976;38:931-38.
12. Olivotto IA, Kan L, Mates D, King S. Screening mammography program of British Columbia: pattern of use and health care system costs. CMAJ 1999;160:337-41.
13. Carlson RW, Anderson BO, Chopra R, Eniu AE, Love RR. Treatment of breast cancer in countries with limited resources. Breast J 2003;9(suppl 2):S67-S74.
14. Jokich PM, Monticciolo DL, Adler YT. Breast ultrasonography. Radiol Clin N Am 1992;30:993-1009.
15. Stavros AT, Thickman D, Rapp DL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-34.
16. Smith DN, Rosenfield Darling ML, Meyer JE, et al. The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies. J Ultrasound Med 2001;20:43-49.
17. Liberman L, Ernberg LA, Heerdt A, et al. Palpable breast masses: is there a role for percutaneous imaging-guided core biopsy? Am J Roentgenol 2000;175:779-87.
18. Vega A, Garijo F, Ortega E. Core needle aspiration biopsy of palpable breast masses. Acta Oncol 1995;34:31-34.
19. Vargas HI, Agbunag RV, Khalkhali I. State of the art of minimally invasive breast biopsy: principles and practice. Breast Cancer 2000;7:1-10.
20. Morris K, Pommier R, Vetto J. Office-based wire-guided open breast biopsy under local anesthesia is accurate and cost effective. Am J Surg 2000;179:422-25.
21. Logan-Young W, Dawson AE, Wilbur DC, et al. The cost-effectiveness of fine-needle aspiration cytology and 14gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma. Cancer 1998;82:1867-73.
22. Rimm D, Stastny J, Rimm E, Ayer S, Frable W. Comparison of the costs of fine-needle aspiration and open surgical biopsy as methods for obtaining a pathologic diagnosis. Cancer 1997;81:51-56.
23. Lannin DR, Silverman JF, Walker C, Pories WJ. Costeffectiveness of fine needle biopsy of the breast. Ann Surg 1986;203:474-80.
24. Pisano ED, Fajardo LL, Tsimikas J, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 Investigators. Cancer 1998;82:679-88.
25. Ciatto S, Bonardi R, Cariaggi MP. Performance of fine-needle aspiration cytology of the breast-multicenter study of 23,063 aspirates in ten Italian laboratories. Tumori 1995;81:13-17.
26. Kim A, Lee J, Choi JS, Won NH, Koo BH. Fine needle aspiration cytology of the breast: experience at an outpatient breast clinic. Acta Cytol 2000;44:361-67.
27. Cohen MB, Rodgers RP, Hales MS, et al. Influence of training and experience in fine-needle aspiration biopsy of breast: receiver operating characteristics curve analysis. Arch Pathol Lab Med 1987;111:518-20.
28. Pennes DR, Naylor B, Rebner M. Fine needle aspiration biopsy of the breast: influence of the number of passes and the sample size on the diagnostic yield. Acta Cytol 1990;34:673-76.
29. Sneige N. Should specimen adequacy be determined by the opinion of the aspirator or by the cells on the slides? Cancer Cytopathol 1997;81:3-5.
30. Morris KT, Pommier RF, Morris A, et al. Usefulness of the triple test score for palpable breast masses. Arch Surg 2001;136:1008-12.
31. National Cancer Institute Sponsored Conference. The uniform approach to breast fine-needle aspiration biopsy. Diagn Cytopathol 1997;16:295-311.
32. Tanaka K, Shoji T, Tominaga Y, et al. Statistical analysis of diagnostic failure of fine needle aspiration cytology (FNAC) in breast cancer. J Surg Oncol 2001;76:100-105.
33. Venegas R, Rutgers J, Cameron B, Vargas H, Butler J. Cytologic evaluation of fine needle aspirated in DCIS. Acta Cytol 1994;38:136-43.
34. Meunier M, Clough K. Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesions. Eur J Radiol 2002;42:10-16.
35. Hoda SA, Rosen PP. Practical considerations in the pathologic diagnosis of needle core biopsies of breast. Am J Clin Pathol 2002;118:101-8.
36. Liberman L, Gougoutas CA, Zakowski MF, et al. Calcifications highly suggestive of malignancy: comparison of breast biopsy methods. AJR Am J Roentgenol 2001;177:165-72.
37. Part VII: breast. In: Green F, Page D, Fleming I, et al., eds. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer, 2002:221-40.
38. TNM Classification of Malignant Tumours, 6th ed. New York: John Wiley & Sons, 2002.
39. Masood S. The expanding role of pathologists in diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program. Breast J 2003;9(suppl 2):S91-S97.